Literature DB >> 16135914

Exploring full-genome sequences for phylogenetic support of HIV-1 transmission events.

Philippe Lemey, Anne-Mieke Vandamme.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16135914     DOI： 10.1097/01.aids.0000182519.92030.ce

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Is there an optimal genetic target for molecular analysis of hepatitis B virus transmission?

Authors:  Benjamin C Cowie
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Using nearly full-genome HIV sequence data improves phylogeny reconstruction in a simulated epidemic.

Authors:  Gonzalo Yebra; Emma B Hodcroft; Manon L Ragonnet-Cronin; Deenan Pillay; Andrew J Leigh Brown
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

3.  Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort.

Authors:  István Bartha; Matthias Assel; Peter M A Sloot; Maurizio Zazzi; Carlo Torti; Eugen Schülter; Andrea De Luca; Anders Sönnerborg; Ana B Abecasis; Kristel Van Laethem; Andrea Rosi; Jenny Svärd; Roger Paredes; David A M C van de Vijver; Anne-Mieke Vandamme; Viktor Müller
Journal:  BMC Infect Dis       Date:  2013-11-12       Impact factor: 3.090

4.  Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.

Authors:  Lize Cuypers; Ana Belén Pérez; Natalia Chueca; Teresa Aldamiz-Echevarría; Juan Carlos Alados; Ana María Martínez-Sapiña; Dolores Merino; Juan Antonio Pineda; Francisco Téllez; Nuria Espinosa; Javier Salméron; Antonio Rivero-Juarez; María Jesús Vivancos; Víctor Hontañón; Anne-Mieke Vandamme; Féderico García
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

Review 5.  Understanding the molecular epidemiology of foot-and-mouth-disease virus.

Authors:  Joern Klein
Journal:  Infect Genet Evol       Date:  2008-11-28       Impact factor: 3.342
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.